Harakiri, BCL2 Interacting Protein (Contains Only BH3 Domain) (HRK) (N-Term) Peptid
HRK
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle HRK Produkte
- HRK (Harakiri, BCL2 Interacting Protein (Contains Only BH3 Domain) (HRK))
- Protein Region
- N-Term
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-HRK antibody (Catalog #: ARP46364_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- HRK (Harakiri, BCL2 Interacting Protein (Contains Only BH3 Domain) (HRK))
- Hintergrund
-
Activator of apoptosis Hrk regulates apoptosis through interaction with death-repressor proteins Bcl-2 and Bcl-X(L). The HRK protein lacks significant homology to other BCL2 family members except for an 8-amino acid region that was similar to the BCL2 hom
Alias Symbols: DP5, HARAKIRI
Protein Interaction Partner: BCL2,BCL2,BCL2A1,BCL2L1,BCL2L1,BCL2L1,BCL2L2,BNC1,BAD,BCL2,BCL2A1,BCL2L1,BCL2L2,C1QBP,BCL2,BCL2A1,BCL2L1,BCL2L2,MCL1
Protein Size: 91 - Molekulargewicht
- 10 kDa
- Gen-ID
- 8739
- NCBI Accession
- NM_003806, NP_003797
- UniProt
- O00198
-
Sie sind hier:
